You are here

Imfinzi

Investors — and AstraZeneca CEO Pascal Soriot — are getting a tad nervous as MYSTIC data loom

Investors — and AstraZeneca CEO Pascal Soriot — are getting a tad nervous as MYSTIC data loom

Endpoints

immuno-oncology

clinical trials

Flag link:

AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next

AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next

Forbes

Flag link:

AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC

AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC

Endpoints

clinical trials

non-small cell lung cancer

Flag link:

Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town

Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town

Fierce Pharma

Flag link:

AstraZeneca's New Drug: Too Little, Too Late?

AstraZeneca's New Drug: Too Little, Too Late?

Seeking Alpha

Flag link: